TLRY
TLRY
NASDAQ · Pharmaceuticals

Tilray Brands Inc

$6.45
+0.24 (+3.86%)
As of Mar 23, 10:04 PM ET ·
Analyst Consensus
Hold
17
Analysts
High
Coverage
Buy 7 41%
Hold 9 53%
Sell 1 6%
Price Target
Analyst Price Target +556.1% upside
Low Target $27.22
Average Target $42.32
High Target $56.32
Current Price $6.45
Current
$6.45
Target
$42.32
$27.22 $42.32 avg $56.32
Scenario Analysis
Bear Case
$27.22
322.0%
Low target
Base Case
$42.32
+556.1%
Avg target
Bull Case
$56.32
+773.2%
High target
Risk/Reward
2.4x
Favorable
Price in Context
52-Week High
$23.20
-72.2% from high
52-Week Low
$3.51
+83.8% from low
Target vs 52W High
$42.32
+82.4% vs high
Next Earnings Report
Apr 6, 2026 · Before Market Open
10d
until earnings
EPS Est: $-0.14
Earnings in 10 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +45.2%
JNJ
Johnson & Johnson
Buy 32 59% $299.55 +24.8%
MRK
Merck & Co. Inc.
Buy 36 67% $159.27 +33.4%
PFE
Pfizer Inc.
Hold 35 40% $33.90 +24.3%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +196.1%
ZTS
Zoetis Inc
Buy 25 64% $209.87 +79.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -22.9%
VTRS
Viatris Inc
Buy 18 67% $122.82 +809.8%